北米のバイオインフォマティクスにおけるAI市場 - 2029年までの産業動向と予測North America AI in Bioinformatics Market - Industry Trends and Forecast to 2029 北米のバイオインフォマティクスAI市場は、2022年の14億4,822万米ドルから2029年には196億7,740万米ドルに達し、2022年から2029年の予測期間中に年平均成長率45.2%で成長すると予測される。 市場細分化: 北... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー北米のバイオインフォマティクスAI市場は、2022年の14億4,822万米ドルから2029年には196億7,740万米ドルに達し、2022年から2029年の予測期間中に年平均成長率45.2%で成長すると予測される。市場細分化: 北米のバイオインフォマティクスにおけるAI市場:オファリング別(サービス、ソフトウェア、その他)、タイプ別(機械学習、ディープラーニング、その他)、製品・サービス別(バイオインフォマティクスサービス、バイオインフォマティクスプラットフォーム、知識管理ツール)、用途別(ゲノム、ケモインフォマティクス&ドラッグデザイン、プロテオミクス、DNAシーケンシング、システムバイオロジー、トランスクリプトミクス、テキストマイニング、マイクロアレイ、メタボロミクス、その他)、セクター(メディカルバイオテクノロジー、動物バイオテクノロジー、植物バイオテクノロジー、環境バイオテクノロジー、法医学バイオテクノロジー、その他)、国(U.S.,産業動向と2029年までの予測 北米のバイオインフォマティクスAI市場ダイナミクスの概要: 促進要因 - 遺伝子配列決定コストの削減 抑制要因 - AIベースの装置のコスト高 機会 - 医療費の増加と大手企業による戦略的イニシアティブ 市場プレイヤー 北米のバイオインフォマティクスAI市場で事業を展開する主な市場プレイヤーを以下に示す: - JADBio & Gnosis Data Analysis社 - SOPHiA GENETICS - Biomax Informatics AG - DNASTAR - アルジゲン - QIAGEN - ソース・バイオサイエンス - ネオジェノミクス・ラボラトリーズ - ユーロフィンズサイエンティフィック - イルミナ社 - サーモフィッシャーサイエンティフィック社 - セルブリッジサイエンス - ダッソー・システムズ - フィオス・ゲノミクス - インシリコ・メディシン - ストランドライフサイエンス - ペイジAI社 - 株式会社ソーマロジック・オペレーティング - iNDX.Ai. - エルシデータ 目次TABLE OF CONTENTS1 INTRODUCTION 12 1.1 OBJECTIVES OF THE STUDY 12 1.2 MARKET DEFINITION 12 1.3 OVERVIEW OF NORTH AMERICA AI IN BIOINFORMATICS MARKET 12 1.4 LIMITATIONS 14 1.5 MARKETS COVERED 14 2 MARKET SEGMENTATION 16 2.1 MARKETS COVERED 16 2.2 GEOGRAPHICAL SCOPE 17 2.3 YEARS CONSIDERED FOR THE STUDY 17 2.4 CURRENCY AND PRICING 17 2.5 DBMR TRIPOD DATA VALIDATION MODEL 18 2.6 MULTIVARIATE MODELLING 21 2.7 OFFERING LIFELINE CURVE 22 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23 2.9 DBMR MARKET POSITION GRID 24 2.10 MARKET SECTOR COVERAGE GRID 25 2.11 VENDOR SHARE ANALYSIS 26 2.12 SECONDARY SOURCES 27 2.13 ASSUMPTIONS 27 3 EXECUTIVE SUMMARY 28 4 PREMIUM INSIGHTS 31 4.1 PESTEL ANALYSIS 32 4.2 PORTER'S FIVE FORCES 33 5 NORTH AMERICA AI IN BIOINFORMATICS MARKET :MARKET OVERVIEW 34 5.1 DRIVERS 36 5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 36 5.1.2 GROWING DEMAND FOR BIOINFORMATICS 38 5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 38 5.2 RESTRAINTS 39 5.2.1 HIGH COST OF INSTRUMENTATION 39 5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 40 5.3 OPPORTUNITIES 42 5.3.1 RISE IN HEALTHCARE EXPENDITURE 42 5.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 43 5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 44 5.4 CHALLENGES 45 5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 45 5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 46 6 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING 48 6.1 OVERVIEW 49 6.2 SERVICES 52 6.3 SOFTWARE 52 6.4 OTHERS 53 7 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE 54 7.1 OVERVIEW 55 7.2 MACHINE LEARNING 58 7.3 DEEP LEARNING 58 7.4 OTHERS 59 8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 60 8.1 OVERVIEW 61 8.2 BIOINFORMATICS SERVICES 64 8.2.1 DATA ANALYSIS 64 8.2.2 SEQUENCING SERVICES 65 8.2.3 DATABASE MANAGEMENT 65 8.2.4 OTHERS 65 8.3 BIOINFORMATICS PLATFORMS 65 8.3.1 SEQUENCE ANALYSIS PLATFORMS 66 8.3.2 SEQUENCE ALIGNMENT PLATFORMS 66 8.3.3 STRUCTURAL ANALYSIS PLATFORMS 66 8.3.4 SEQUENCE MANIPULATION PLATFORMS 66 8.3.5 OTHERS 66 8.4 KNOWLEDGE MANAGEMENT TOOLS 67 8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 67 8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 67 9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION 68 9.1 OVERVIEW 69 9.2 GENOMICS 72 9.3 CHEMOINFORMATICS & DRUG DESIGN 72 9.4 PROTEOMICS 73 9.5 DNA SEQUENCING 73 9.6 SYSTEM BIOLOGY 74 9.7 TRANSCRIPTOMICS 74 9.8 TEXT MINING 75 9.9 MICROARRAYS 75 9.10 METABOLOMICS 76 9.11 OTHERS 76 10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR 77 10.1 OVERVIEW 78 10.2 MEDICAL BIOTECHNOLOGY 81 10.3 ANIMAL BIOTECHNOLOGY 81 10.4 PLANT BIOTECHNOLOGY 82 10.5 ENVIRONMENTAL BIOTECHNOLOGY 82 10.6 FORENSIC BIOTECHNOLOGY 83 10.7 OTHERS 83 11 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY COUNTRY 84 11.1 U.S. 90 11.2 CANADA 93 11.3 MEXICO 96 12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 99 12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 99 13 SWOT ANALYSIS 100 14 COMPANY PROFILE 101 14.1 ILLUMINA, INC. 101 14.1.1 COMPANY SNAPSHOT 101 14.1.2 REVENUE ANALYSIS 101 14.1.3 PRODUCT PORTFOLIO 102 14.1.4 RECENT DEVELOPMENTS 102 14.2 DASSAULT SYSTEMES 103 14.2.1 COMPANY SNAPSHOT 103 14.2.2 REVENUE ANALYSIS 103 14.2.3 PRODUCT PORTFOLIO 104 14.2.4 RECENT DEVELOPMENT 104 14.3 EUROFINS SCIENTIFIC 105 14.3.1 COMPANY SNAPSHOT 105 14.3.2 REVENUE ANALYSIS 105 14.3.3 PRODUCT PORTFOLIO 106 14.3.4 RECENT DEVELOPMENT 106 14.4 THERMO FISHER SCIENTIFIC INC. 107 14.4.1 COMPANY SNAPSHOT 107 14.4.2 REVENUE ANALYSIS 107 14.4.3 PRODUCT PORTFOLIO 108 14.4.4 RECENT DEVELOPMENT 108 14.5 QIAGEN 109 14.5.1 COMPANY SNAPSHOT 109 14.5.2 PRODUCT PORTFOLIO 109 14.5.3 RECENT DEVELOPMENT 109 14.6 ARDIGEN 110 14.6.1 COMPANY SNAPSHOT 110 14.6.2 PRODUCT PORTFOLIO 110 14.6.3 RECENT DEVELOPMENT 110 14.7 BIOMAX INFORMATICS AG 111 14.7.1 COMPANY SNAPSHOT 111 14.7.2 PRODUCT PORTFOLIO 111 14.7.3 RECENT DEVELOPMENT 111 14.8 CELBRIDGESCIENCE. 112 14.8.1 COMPANY SNAPSHOT 112 14.8.2 PRODUCT PORTFOLIO 112 14.8.3 RECENT DEVELOPMENTS 112 14.9 DNASTAR 113 14.9.1 COMPANY SNAPSHOT 113 14.9.2 PRODUCT PORTFOLIO 113 14.9.3 RECENT DEVELOPMENT 113 14.10 ELUCIDATA 114 14.10.1 COMPANY SNAPSHOT 114 14.10.2 PRODUCT PORTFOLIO 114 14.10.3 RECENT DEVELOPMENT 114 14.11 INDX. AI. 115 14.11.1 COMPANY SNAPSHOT 115 14.11.2 PRODUCT PORTFOLIO 115 14.11.3 RECENT DEVELOPMENTS 115 14.12 INSILICO MEDICINE 116 14.12.1 COMPANY SNAPSHOT 116 14.12.2 PRODUCT PORTFOLIO 116 14.12.3 RECENT DEVELOPMENTS 116 14.13 JADBIO & GNOSIS DATA ANALYSIS 117 14.13.1 COMPANY SNAPSHOT 117 14.13.2 PRODUCT PORTFOLIO 117 14.13.3 RECENT DEVELOPMENTS 117 14.14 NEOGENOMICS LABORATORIES 118 14.14.1 COMPANY SNAPSHOT 118 14.14.2 REVENUE ANALYSIS 118 14.14.3 PRODUCT PORTFOLIO 119 14.14.4 RECENT DEVELOPMENT 119 14.15 PAIGE AI, INC. 120 14.15.1 COMPANY SNAPSHOT 120 14.15.2 PRODUCT PORTFOLIO 120 14.15.3 RECENT DEVELOPMENT 120 14.16 SOMALOGIC OPERATING CO., INC. 121 14.16.1 COMPANY SNAPSHOT 121 14.16.2 PRODUCT PORTFOLIO 121 14.16.3 RECENT DEVELOPMENT 121 14.17 SOPHIA GENETICS 122 14.17.1 COMPANY SNAPSHOT 122 14.17.2 PRODUCT PORTFOLIO 122 14.17.3 RECENT DEVELOPMENT 122 14.18 SOURCE BIOSCIENCE. 123 14.18.1 COMPANY SNAPSHOT 123 14.18.2 PRODUCT PORTFOLIO 123 14.18.3 RECENT DEVELOPMENT 123 15 QUESTIONNAIRE 124 16 RELATED REPORTS 127
SummaryNorth America AI in bioinformatics market is expected to reach USD 19,677.40 million by 2029 from USD 1,448.22 million in 2022, growing at a CAGR of 45.2% during the forecast period of 2022 to 2029. Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 12 1.1 OBJECTIVES OF THE STUDY 12 1.2 MARKET DEFINITION 12 1.3 OVERVIEW OF NORTH AMERICA AI IN BIOINFORMATICS MARKET 12 1.4 LIMITATIONS 14 1.5 MARKETS COVERED 14 2 MARKET SEGMENTATION 16 2.1 MARKETS COVERED 16 2.2 GEOGRAPHICAL SCOPE 17 2.3 YEARS CONSIDERED FOR THE STUDY 17 2.4 CURRENCY AND PRICING 17 2.5 DBMR TRIPOD DATA VALIDATION MODEL 18 2.6 MULTIVARIATE MODELLING 21 2.7 OFFERING LIFELINE CURVE 22 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23 2.9 DBMR MARKET POSITION GRID 24 2.10 MARKET SECTOR COVERAGE GRID 25 2.11 VENDOR SHARE ANALYSIS 26 2.12 SECONDARY SOURCES 27 2.13 ASSUMPTIONS 27 3 EXECUTIVE SUMMARY 28 4 PREMIUM INSIGHTS 31 4.1 PESTEL ANALYSIS 32 4.2 PORTER'S FIVE FORCES 33 5 NORTH AMERICA AI IN BIOINFORMATICS MARKET :MARKET OVERVIEW 34 5.1 DRIVERS 36 5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 36 5.1.2 GROWING DEMAND FOR BIOINFORMATICS 38 5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 38 5.2 RESTRAINTS 39 5.2.1 HIGH COST OF INSTRUMENTATION 39 5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 40 5.3 OPPORTUNITIES 42 5.3.1 RISE IN HEALTHCARE EXPENDITURE 42 5.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 43 5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 44 5.4 CHALLENGES 45 5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 45 5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 46 6 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING 48 6.1 OVERVIEW 49 6.2 SERVICES 52 6.3 SOFTWARE 52 6.4 OTHERS 53 7 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE 54 7.1 OVERVIEW 55 7.2 MACHINE LEARNING 58 7.3 DEEP LEARNING 58 7.4 OTHERS 59 8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 60 8.1 OVERVIEW 61 8.2 BIOINFORMATICS SERVICES 64 8.2.1 DATA ANALYSIS 64 8.2.2 SEQUENCING SERVICES 65 8.2.3 DATABASE MANAGEMENT 65 8.2.4 OTHERS 65 8.3 BIOINFORMATICS PLATFORMS 65 8.3.1 SEQUENCE ANALYSIS PLATFORMS 66 8.3.2 SEQUENCE ALIGNMENT PLATFORMS 66 8.3.3 STRUCTURAL ANALYSIS PLATFORMS 66 8.3.4 SEQUENCE MANIPULATION PLATFORMS 66 8.3.5 OTHERS 66 8.4 KNOWLEDGE MANAGEMENT TOOLS 67 8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 67 8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 67 9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION 68 9.1 OVERVIEW 69 9.2 GENOMICS 72 9.3 CHEMOINFORMATICS & DRUG DESIGN 72 9.4 PROTEOMICS 73 9.5 DNA SEQUENCING 73 9.6 SYSTEM BIOLOGY 74 9.7 TRANSCRIPTOMICS 74 9.8 TEXT MINING 75 9.9 MICROARRAYS 75 9.10 METABOLOMICS 76 9.11 OTHERS 76 10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR 77 10.1 OVERVIEW 78 10.2 MEDICAL BIOTECHNOLOGY 81 10.3 ANIMAL BIOTECHNOLOGY 81 10.4 PLANT BIOTECHNOLOGY 82 10.5 ENVIRONMENTAL BIOTECHNOLOGY 82 10.6 FORENSIC BIOTECHNOLOGY 83 10.7 OTHERS 83 11 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY COUNTRY 84 11.1 U.S. 90 11.2 CANADA 93 11.3 MEXICO 96 12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 99 12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 99 13 SWOT ANALYSIS 100 14 COMPANY PROFILE 101 14.1 ILLUMINA, INC. 101 14.1.1 COMPANY SNAPSHOT 101 14.1.2 REVENUE ANALYSIS 101 14.1.3 PRODUCT PORTFOLIO 102 14.1.4 RECENT DEVELOPMENTS 102 14.2 DASSAULT SYSTEMES 103 14.2.1 COMPANY SNAPSHOT 103 14.2.2 REVENUE ANALYSIS 103 14.2.3 PRODUCT PORTFOLIO 104 14.2.4 RECENT DEVELOPMENT 104 14.3 EUROFINS SCIENTIFIC 105 14.3.1 COMPANY SNAPSHOT 105 14.3.2 REVENUE ANALYSIS 105 14.3.3 PRODUCT PORTFOLIO 106 14.3.4 RECENT DEVELOPMENT 106 14.4 THERMO FISHER SCIENTIFIC INC. 107 14.4.1 COMPANY SNAPSHOT 107 14.4.2 REVENUE ANALYSIS 107 14.4.3 PRODUCT PORTFOLIO 108 14.4.4 RECENT DEVELOPMENT 108 14.5 QIAGEN 109 14.5.1 COMPANY SNAPSHOT 109 14.5.2 PRODUCT PORTFOLIO 109 14.5.3 RECENT DEVELOPMENT 109 14.6 ARDIGEN 110 14.6.1 COMPANY SNAPSHOT 110 14.6.2 PRODUCT PORTFOLIO 110 14.6.3 RECENT DEVELOPMENT 110 14.7 BIOMAX INFORMATICS AG 111 14.7.1 COMPANY SNAPSHOT 111 14.7.2 PRODUCT PORTFOLIO 111 14.7.3 RECENT DEVELOPMENT 111 14.8 CELBRIDGESCIENCE. 112 14.8.1 COMPANY SNAPSHOT 112 14.8.2 PRODUCT PORTFOLIO 112 14.8.3 RECENT DEVELOPMENTS 112 14.9 DNASTAR 113 14.9.1 COMPANY SNAPSHOT 113 14.9.2 PRODUCT PORTFOLIO 113 14.9.3 RECENT DEVELOPMENT 113 14.10 ELUCIDATA 114 14.10.1 COMPANY SNAPSHOT 114 14.10.2 PRODUCT PORTFOLIO 114 14.10.3 RECENT DEVELOPMENT 114 14.11 INDX. AI. 115 14.11.1 COMPANY SNAPSHOT 115 14.11.2 PRODUCT PORTFOLIO 115 14.11.3 RECENT DEVELOPMENTS 115 14.12 INSILICO MEDICINE 116 14.12.1 COMPANY SNAPSHOT 116 14.12.2 PRODUCT PORTFOLIO 116 14.12.3 RECENT DEVELOPMENTS 116 14.13 JADBIO & GNOSIS DATA ANALYSIS 117 14.13.1 COMPANY SNAPSHOT 117 14.13.2 PRODUCT PORTFOLIO 117 14.13.3 RECENT DEVELOPMENTS 117 14.14 NEOGENOMICS LABORATORIES 118 14.14.1 COMPANY SNAPSHOT 118 14.14.2 REVENUE ANALYSIS 118 14.14.3 PRODUCT PORTFOLIO 119 14.14.4 RECENT DEVELOPMENT 119 14.15 PAIGE AI, INC. 120 14.15.1 COMPANY SNAPSHOT 120 14.15.2 PRODUCT PORTFOLIO 120 14.15.3 RECENT DEVELOPMENT 120 14.16 SOMALOGIC OPERATING CO., INC. 121 14.16.1 COMPANY SNAPSHOT 121 14.16.2 PRODUCT PORTFOLIO 121 14.16.3 RECENT DEVELOPMENT 121 14.17 SOPHIA GENETICS 122 14.17.1 COMPANY SNAPSHOT 122 14.17.2 PRODUCT PORTFOLIO 122 14.17.3 RECENT DEVELOPMENT 122 14.18 SOURCE BIOSCIENCE. 123 14.18.1 COMPANY SNAPSHOT 123 14.18.2 PRODUCT PORTFOLIO 123 14.18.3 RECENT DEVELOPMENT 123 15 QUESTIONNAIRE 124 16 RELATED REPORTS 127
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療IT)の最新刊レポート
Data Bridge Market Research社の医療IT分野での最新刊レポート本レポートと同じKEY WORD(ai)の最新刊レポート
よくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|